Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Vanda Pharmaceuticals Inc. (VNDA)  
$4.78 0.04 (0.83%) as of 4:30 Fri 6/27


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 61,398,000
Market Cap: 293.48(M)
Last Volume: 716,308 Avg Vol: 691,375
52 Week Range: $3.92 - $6.34
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    : 7.5
Insider 6 Months    : 11.9
Insider 3/6 Months : 19.8
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Vanda Pharmaceuticals is a biopharmaceutical company. Co.'s commercial portfolio is comprised of two products, HETLIOZ® for the treatment of Non-24 Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome and Fanapt® for the treatment of schizophrenia. In addition, Co. has a number of drugs in development, including: Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist, for the treatment of gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia; and VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for several oncology indications.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 30,000 102,000 102,000 102,000
Total Buy Value $128,467 $472,136 $472,136 $472,136
Total People Bought 1 2 2 2
Total Buy Transactions 2 10 10 10
Total Shares Sold 7,000 7,000 9,251 142,785
Total Sell Value $32,130 $32,130 $45,457 $633,844
Total People Sold 1 1 2 6
Total Sell Transactions 1 1 2 15
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 287
  Page 1 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mitchell Stephen Ray   –       •      –    2025-06-13 4 S $4.59 $32,130 D/D (7,000) 97,082 -6%     
   Ward Anne Sempowski   –       •      –    2025-06-05 4 A $0.00 $0 D/D 59,225 119,067     -
   Chrousos Phaedra   –       •      –    2025-06-05 4 A $0.00 $0 D/D 59,225 123,350     -
   Mitchell Stephen Ray   –       •      –    2025-06-05 4 A $0.00 $0 D/D 59,225 104,082     -
   Honore Tage   –       •      –    2025-06-05 4 A $0.00 $0 D/D 59,225 123,469     -
   Dugan Richard W   –       •      –    2025-06-05 4 A $0.00 $0 D/D 59,225 177,454     -
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2025-05-21 4 B $4.39 $43,995 D/D 10,000 2,325,731 0.01 11%     
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2025-05-16 4 B $4.22 $84,472 D/D 20,000 2,315,731 0.01 15%     
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2025-03-06 4 B $5.01 $50,150 D/D 10,000 2,295,731 0.01 -3%     
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2025-03-05 4 B $5.01 $50,200 D/D 10,000 2,285,731 0.01 -7%     
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2025-03-03 4 B $4.71 $47,050 D/D 10,000 2,275,731 0.01 1%     
   Wijkstrom Joakim SVP, Chief Marketing Officer   •       –      –    2025-03-01 4 D $4.76 $73,875 D/D (15,520) 239,269     -
   Williams Timothy SVP & General Counsel   •       –      –    2025-03-01 4 D $4.76 $128,239 D/D (26,941) 294,884     -
   Birznieks Gunther SVP, Business Development   •       –      –    2025-03-01 4 D $4.76 $128,239 D/D (26,941) 411,628     -
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2025-03-01 4 D $4.76 $456,955 D/D (95,999) 2,265,731     -
   Moran Kevin Patrick SVP, CFO & Treasurer   •       –      –    2025-03-01 4 D $4.76 $128,239 D/D (26,941) 328,822     -
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2025-02-28 4 B $4.76 $47,600 D/D 10,000 2,361,730 0.01 0%     
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2025-02-27 4 B $4.76 $47,600 D/D 10,000 2,351,730 0.01 2%     
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2025-02-26 4 B $4.75 $47,650 D/D 10,000 2,341,730 0.01 1%     
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2025-02-25 4 B $4.46 $44,640 D/D 10,000 2,331,730 0.01 7%     
   Moran Kevin Patrick SVP, CFO & Treasurer   •       –      –    2025-02-21 4 B $4.39 $8,779 D/D 2,000 355,763 0.01 8%     
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2025-02-18 4 A $0.00 $0 D/D 450,000 2,321,730     -
   Moran Kevin Patrick SVP, CFO & Treasurer   •       –      –    2025-02-18 4 A $0.00 $0 D/D 125,000 353,763     -
   Birznieks Gunther SVP, Business Development   •       –      –    2025-02-18 4 A $0.00 $0 D/D 125,000 438,569     -
   Wijkstrom Joakim SVP, Chief Marketing Officer   •       –      –    2025-02-18 4 A $0.00 $0 D/D 125,000 254,789     -
  287 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us